Cancer - July 2014 Archives

On Saturday, July 12, at 9 a.m. CT, we’ll talk about the groundbreaking research involving the measles virus to fight cancer. The process is called oncolytic virotherapy and Dr. Stephen Russell will be our guest, along with his patient Stacy Erholtz who received 10 million doses – a seemingly lethal amount – of the measles virus to treat her multiple myeloma. The Wall Street Journal article on Health Trackers is found here. WATCH this video: https://www.youtube.com/watch?v=LImk-KdMT1w This Saturday we’ll hear more about Stacy’s amazing story, discuss with Dr. Russell the science behind virus therapy and learn where future research might be headed. Are there other diseases that could be cured by using viruses? Where did all those doses of measles vaccine come from? It’s a remarkable development in the future of medicine. Join us. To listen to the program on Saturday, click here.  More information about Living Organ Donation can be found here.   The Living Donor Evaluation Form can be found here.  The Mayo Transplant Center can be reached at 866-227-1569 Mayo Clinic Radio is available on iHeart Radio. Listen to this week’s Medical News Headlines: News Segment July 12, 2014 (right click MP3) 

Miss the show? Here is the podcast: Mayo Clinic Radio Full Show 7-12-2014  On Saturday, July 12, at 9 a.m. CT, we’ll talk about the ...

Tips for cancer survivors to keep cool in the summer heat Cancer survivors should be careful this season — there's potential for dehydration and ...

JACKSONVILLE, Flórida —Análises genômicas de carcinomas de células renais de células claras (ccRCC — clear cell renal cell carcinoma) de 72 pacientes, revelaram 31 genes que são peças-chave no desenvolvimento, crescimento e disseminação do câncer, informam pesquisadores da Clínica Mayo de Jacksonville, na Flórida. Desses genes, oito não haviam sido relacionados, anteriormente, ao câncer de rim; e outros seis genes, ao que se sabia até então, nunca foram ligados a qualquer forma de câncer. O ccRCC é a forma mais comum de câncer de rim. http://youtu.be/vGxDshbW0LU

Rochester, Minn. -- A new study by radiation oncologists at Mayo Clinic comparing the world’s literature on outcomes of proton beam therapy in the treatment of a variety of advanced head and neck cancers of the skull base compared to intensity modulated radiation therapy (IMRT) has found that proton beam therapy significantly improved disease free survival and tumor control when compared to IMRT. The results appear in the journal Lancet Oncology. https://www.youtube.com/watch?v=1WCtOW_KOxk “We undertook a systematic review and meta-analysis to compare the clinical outcomes of patients treated with proton therapy with patients receiving photon IMRT,” says senior author Robert Foote, M.D., a radiation oncologist at Mayo Clinic. “Our findings suggest that the theoretical advantages of proton beam therapy may in fact be real.”

JACKSONVILLE, Fla. — A genomic analysis of clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer, from 72 patients has uncovered 31 genes that are key to development, growth and spread of the cancer, say researchers from Mayo Clinic in Florida. Eight of these genes had not been previously linked to kidney cancer, and six other genes were never known to be involved in any form of cancer. http://youtu.be/vGxDshbW0LU   Their study, in the journal Oncotarget, is the most extensive analysis to date of gene expression’s role in ccRCC tumor growth and metastasis. The ccRCC subtype accounts for 80 percent of all kidney cancer cases.